Home › Lung Diseases › New Mexico › Albuquerque
Lung Diseases clinical trials in Albuquerque, NM
3 studies for Lung Diseases are looking for participants at sites in and around Albuquerque (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
RecruitingPhase 2
- New Mexico Oncology Hematology Consultants, Ltd, Albuquerque
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RecruitingPhase 2
- Clinical Research Site, Albuquerque
About Lung Diseases
Lung diseases are disorders or infections that affect the lungs and cause breathing problems. Some can lead to respiratory failure. Find out more about prevention, living with lung diseases, and treatment.
More about Lung Diseases on MedlinePlus
Lung Diseases trials in other cities
- Houston, TX16 studies
- Boston, MA14 studies
- Durham, NC13 studies
- New York City, NY13 studies
- Pittsburgh, PA11 studies
- Dallas, TX10 studies
- Los Angeles, CA10 studies
- Ann Arbor, MI10 studies
- Miami, FL10 studies
- Columbus, OH10 studies
- Chicago, IL9 studies
- Washington, DC9 studies
Other studies in Albuquerque
- Breast Cancer17 studies
- Non-Small Cell Lung Cancer17 studies
- Cancer (all types)14 studies
- Lung Cancer14 studies
- Ovarian Cancer13 studies
- Endometrial Cancer12 studies
- Cardiovascular Disease11 studies
- Metastatic Cancer11 studies
- Prostate Cancer10 studies
- Type 2 Diabetes10 studies
- Acute Myeloid Leukemia9 studies
- Melanoma9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.